MDT Annual CFF
-$4.45 B
+$510.00 M+10.28%
30 April 2024
Summary:
As of January 22, 2025, MDT annual cash flow from financing activities is -$4.45 billion, with the most recent change of +$510.00 million (+10.28%) on April 30, 2024. During the last 3 years, it has fallen by -$314.00 million (-7.59%). MDT annual CFF is now -127.90% below its all-time high of $15.95 billion, reached on April 24, 2015.MDT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MDT Quarterly CFF
-$534.00 M
+$197.00 M+26.95%
25 October 2024
Summary:
As of January 22, 2025, MDT quarterly cash flow from financing activities is -$534.00 million, with the most recent change of +$197.00 million (+26.95%) on October 25, 2024. Over the past year, it has dropped by -$444.00 million (-493.33%). MDT quarterly CFF is now -103.58% below its all-time high of $14.93 billion, reached on January 31, 2015.MDT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MDT TTM CFF
-$5.12 B
-$444.00 M-9.49%
25 October 2024
Summary:
As of January 22, 2025, MDT TTM cash flow from financing activities is -$5.12 billion, with the most recent change of -$444.00 million (-9.49%) on October 25, 2024. Over the past year, it has increased by +$2.49 billion (+32.71%). MDT TTM CFF is now -132.13% below its all-time high of $15.95 billion, reached on April 24, 2015.MDT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MDT Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.3% | -493.3% | +32.7% |
| 3 y3 years | -7.6% | +54.6% | +39.8% |
| 5 y5 years | +18.1% | +69.3% | -23.7% |
MDT Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.6% | +16.6% | -117.7% | +89.1% | -382.5% | +39.8% |
| 5 y | 5-year | -7.6% | +18.1% | -117.7% | +89.6% | -2568.8% | +39.8% |
| alltime | all time | -127.9% | +62.8% | -103.6% | +91.3% | -132.1% | +58.6% |
Medtronic Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | - | -$534.00 M(-26.9%) | -$5.12 B(+9.5%) |
| July 2024 | - | -$731.00 M(-69.0%) | -$4.68 B(+5.2%) |
| Apr 2024 | -$4.45 B(-10.3%) | -$2.36 B(+57.3%) | -$4.45 B(-36.3%) |
| Jan 2024 | - | -$1.50 B(+1566.7%) | -$6.98 B(-8.3%) |
| Oct 2023 | - | -$90.00 M(-82.0%) | -$7.62 B(+68.8%) |
| July 2023 | - | -$501.00 M(-89.8%) | -$4.51 B(-9.1%) |
| Apr 2023 | - | -$4.89 B(+129.1%) | -$4.96 B(+145.7%) |
| Apr 2023 | -$4.96 B(-7.0%) | - | - |
| Jan 2023 | - | -$2.13 B(-170.8%) | -$2.02 B(+90.1%) |
| Oct 2022 | - | $3.01 B(-417.3%) | -$1.06 B(-79.7%) |
| July 2022 | - | -$950.00 M(-51.3%) | -$5.23 B(-2.0%) |
| Apr 2022 | -$5.34 B(+29.0%) | -$1.95 B(+65.6%) | -$5.34 B(-37.3%) |
| Jan 2022 | - | -$1.18 B(+1.9%) | -$8.52 B(+2.1%) |
| Oct 2021 | - | -$1.16 B(+9.5%) | -$8.34 B(+16.6%) |
| July 2021 | - | -$1.05 B(-79.4%) | -$7.15 B(+72.9%) |
| Apr 2021 | -$4.14 B(-1.5%) | -$5.13 B(+413.9%) | -$4.14 B(+1204.7%) |
| Jan 2021 | - | -$998.00 M(-3218.8%) | -$317.00 M(+65.1%) |
| Oct 2020 | - | $32.00 M(-98.4%) | -$192.00 M(-90.2%) |
| July 2020 | - | $1.96 B(-249.5%) | -$1.97 B(-53.2%) |
| Apr 2020 | -$4.20 B(-22.7%) | -$1.31 B(+50.1%) | -$4.20 B(+12.0%) |
| Jan 2020 | - | -$873.00 M(-49.9%) | -$3.75 B(-9.5%) |
| Oct 2019 | - | -$1.74 B(+535.4%) | -$4.14 B(+0.3%) |
| July 2019 | - | -$274.00 M(-68.1%) | -$4.13 B(-23.9%) |
| Apr 2019 | -$5.43 B(-54.6%) | -$860.00 M(-32.2%) | -$5.43 B(-35.3%) |
| Jan 2019 | - | -$1.27 B(-26.7%) | -$8.40 B(+5.3%) |
| Oct 2018 | - | -$1.73 B(+10.0%) | -$7.98 B(-35.6%) |
| July 2018 | - | -$1.57 B(-58.9%) | -$12.39 B(+3.6%) |
| Apr 2018 | -$11.95 B(+264.1%) | -$3.83 B(+350.9%) | -$11.95 B(+60.7%) |
| Jan 2018 | - | -$849.00 M(-86.2%) | -$7.44 B(-5.9%) |
| Oct 2017 | - | -$6.14 B(+437.8%) | -$7.91 B(+142.3%) |
| July 2017 | - | -$1.14 B(-266.1%) | -$3.26 B(-0.6%) |
| Apr 2017 | -$3.28 B(-65.6%) | $687.00 M(-152.1%) | -$3.28 B(-66.6%) |
| Jan 2017 | - | -$1.32 B(-11.5%) | -$9.84 B(+1.7%) |
| Oct 2016 | - | -$1.49 B(+28.5%) | -$9.67 B(+7.9%) |
| July 2016 | - | -$1.16 B(-80.2%) | -$8.96 B(-6.1%) |
| Apr 2016 | -$9.54 B(-159.8%) | -$5.87 B(+409.2%) | -$9.54 B(+277.8%) |
| Jan 2016 | - | -$1.15 B(+47.5%) | -$2.53 B(-118.6%) |
| Oct 2015 | - | -$781.00 M(-55.2%) | $13.55 B(-6.9%) |
| July 2015 | - | -$1.74 B(-251.5%) | $14.56 B(-8.7%) |
| Apr 2015 | $15.95 B(-1837.4%) | $1.15 B(-92.3%) | $15.95 B(+13.3%) |
| Jan 2015 | - | $14.93 B(+6446.1%) | $14.08 B(-1528.1%) |
| Oct 2014 | - | $228.00 M(-164.2%) | -$986.00 M(+15.9%) |
| July 2014 | - | -$355.00 M(-50.5%) | -$851.00 M(-7.3%) |
| Apr 2014 | -$918.00 M(-56.3%) | -$717.00 M(+404.9%) | -$918.00 M(-20.4%) |
| Jan 2014 | - | -$142.00 M(-139.1%) | -$1.15 B(-17.5%) |
| Oct 2013 | - | $363.00 M(-186.0%) | -$1.40 B(-25.6%) |
| July 2013 | - | -$422.00 M(-55.7%) | -$1.88 B(-10.5%) |
| Apr 2013 | -$2.10 B(+11.6%) | -$952.00 M(+146.0%) | -$2.10 B(+24.7%) |
| Jan 2013 | - | -$387.00 M(+225.2%) | -$1.69 B(-6.4%) |
| Oct 2012 | - | -$119.00 M(-81.5%) | -$1.80 B(-11.2%) |
| July 2012 | - | -$643.00 M(+20.0%) | -$2.03 B(+7.8%) |
| Apr 2012 | -$1.88 B(-6.2%) | -$536.00 M(+6.8%) | -$1.88 B(-25.6%) |
| Jan 2012 | - | -$502.00 M(+44.7%) | -$2.53 B(+4.5%) |
| Oct 2011 | - | -$347.00 M(-30.2%) | -$2.42 B(-1.4%) |
| July 2011 | - | -$497.00 M(-58.1%) | -$2.46 B(+22.5%) |
| Apr 2011 | -$2.01 B(-362.6%) | -$1.19 B(+200.8%) | -$2.01 B(-421.5%) |
| Jan 2011 | - | -$394.00 M(+3.4%) | $624.00 M(-9.0%) |
| Oct 2010 | - | -$381.00 M(+728.3%) | $686.00 M(-38.3%) |
| July 2010 | - | -$46.00 M(-103.2%) | $1.11 B(+45.5%) |
| Apr 2010 | $764.00 M(-190.4%) | $1.45 B(-535.2%) | $764.00 M(-347.2%) |
| Jan 2010 | - | -$332.00 M(-837.8%) | -$309.00 M(+200.0%) |
| Oct 2009 | - | $45.00 M(-111.4%) | -$103.00 M(-91.7%) |
| July 2009 | - | -$394.00 M(-205.9%) | -$1.24 B(+47.1%) |
| Apr 2009 | -$845.00 M(+1.2%) | $372.00 M(-395.2%) | -$845.00 M(-37.7%) |
| Jan 2009 | - | -$126.00 M(-88.5%) | -$1.36 B(+2.4%) |
| Oct 2008 | - | -$1.09 B(<-9900.0%) | -$1.32 B(+429.6%) |
| July 2008 | - | $4.00 M(-102.9%) | -$250.00 M(-70.1%) |
| Apr 2008 | -$835.00 M | -$139.00 M(+47.9%) | -$835.00 M(-38.3%) |
| Jan 2008 | - | -$94.00 M(+347.6%) | -$1.35 B(+6.4%) |
| Oct 2007 | - | -$21.00 M(-96.4%) | -$1.27 B(-62.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2007 | - | -$581.00 M(-11.6%) | -$3.42 B(+13.6%) |
| Apr 2007 | -$3.01 B(-328.8%) | -$657.00 M(+4953.8%) | -$3.01 B(+51.8%) |
| Jan 2007 | - | -$13.00 M(-99.4%) | -$1.98 B(+6.5%) |
| Oct 2006 | - | -$2.17 B(+1153.2%) | -$1.86 B(-585.2%) |
| July 2006 | - | -$173.00 M(-146.8%) | $384.00 M(-70.8%) |
| Apr 2006 | $1.32 B(-369.1%) | $370.00 M(+242.6%) | $1.32 B(+29.9%) |
| Jan 2006 | - | $108.00 M(+36.7%) | $1.01 B(+49.7%) |
| Oct 2005 | - | $79.00 M(-89.6%) | $676.80 M(+49.6%) |
| July 2005 | - | $759.00 M(+1032.8%) | $452.30 M(-192.5%) |
| Apr 2005 | -$489.00 M(-51.6%) | $67.00 M(-129.4%) | -$489.00 M(-45.4%) |
| Jan 2005 | - | -$228.20 M(+56.8%) | -$895.10 M(+12.1%) |
| Oct 2004 | - | -$145.50 M(-20.2%) | -$798.30 M(-20.6%) |
| July 2004 | - | -$182.30 M(-46.2%) | -$1.01 B(-0.4%) |
| Apr 2004 | -$1.01 B(+35.8%) | -$339.10 M(+158.1%) | -$1.01 B(+7.9%) |
| Jan 2004 | - | -$131.40 M(-62.8%) | -$936.20 M(+3.7%) |
| Oct 2003 | - | -$352.80 M(+88.9%) | -$902.50 M(+15.1%) |
| July 2003 | - | -$186.80 M(-29.6%) | -$784.30 M(+5.4%) |
| Apr 2003 | -$743.80 M(-134.3%) | -$265.20 M(+171.4%) | -$743.80 M(+78.5%) |
| Jan 2003 | - | -$97.70 M(-58.4%) | -$416.80 M(+102.2%) |
| Oct 2002 | - | -$234.60 M(+60.4%) | -$206.10 M(-109.8%) |
| July 2002 | - | -$146.30 M(-336.7%) | $2.10 B(-3.2%) |
| Apr 2002 | $2.17 B(-981.4%) | $61.80 M(-45.3%) | $2.17 B(+4.8%) |
| Jan 2002 | - | $113.00 M(-94.5%) | $2.07 B(+6.8%) |
| Oct 2001 | - | $2.07 B(-2778.6%) | $1.94 B(-1025.9%) |
| July 2001 | - | -$77.20 M(+112.1%) | -$209.00 M(-14.9%) |
| Apr 2001 | -$245.70 M(-42.3%) | -$36.40 M(+89.6%) | -$245.70 M(-10.5%) |
| Jan 2001 | - | -$19.20 M(-74.8%) | -$274.60 M(-4.7%) |
| Oct 2000 | - | -$76.20 M(-33.1%) | -$288.10 M(-26.8%) |
| July 2000 | - | -$113.90 M(+74.4%) | -$393.40 M(-7.7%) |
| Apr 2000 | -$426.00 M(-170.4%) | -$65.30 M(+99.7%) | -$426.00 M(-7.0%) |
| Jan 2000 | - | -$32.70 M(-82.0%) | -$458.30 M(-48.7%) |
| Oct 1999 | - | -$181.50 M(+23.9%) | -$893.60 M(-264.1%) |
| July 1999 | - | -$146.50 M(+50.1%) | $544.40 M(-10.0%) |
| Apr 1999 | $604.80 M(-581.1%) | -$97.60 M(-79.1%) | $604.80 M(-16.4%) |
| Jan 1999 | - | -$468.00 M(-137.2%) | $723.20 M(-37.7%) |
| Oct 1998 | - | $1.26 B(-1559.3%) | $1.16 B(-835.9%) |
| July 1998 | - | -$86.10 M(-513.9%) | -$157.80 M(+25.5%) |
| Apr 1998 | -$125.70 M(-65.4%) | $20.80 M(-169.3%) | -$125.70 M(-71.0%) |
| Jan 1998 | - | -$30.00 M(-52.0%) | -$434.10 M(-6.8%) |
| Oct 1997 | - | -$62.50 M(+15.7%) | -$465.70 M(+21.3%) |
| July 1997 | - | -$54.00 M(-81.2%) | -$383.80 M(+5.7%) |
| Apr 1997 | -$363.10 M(+2074.3%) | -$287.60 M(+366.9%) | -$363.10 M(+850.5%) |
| Jan 1997 | - | -$61.60 M(-417.5%) | -$38.20 M(-661.8%) |
| Oct 1996 | - | $19.40 M(-158.3%) | $6.80 M(-115.6%) |
| July 1996 | - | -$33.30 M(-189.3%) | -$43.50 M(+160.5%) |
| Apr 1996 | -$16.70 M(-89.5%) | $37.30 M(-324.7%) | -$16.70 M(-77.6%) |
| Jan 1996 | - | -$16.60 M(-46.3%) | -$74.50 M(+64.5%) |
| Oct 1995 | - | -$30.90 M(+375.4%) | -$45.30 M(-49.4%) |
| July 1995 | - | -$6.50 M(-68.3%) | -$89.50 M(-44.0%) |
| Apr 1995 | -$159.70 M(+138.7%) | -$20.50 M(-262.7%) | -$159.70 M(+85.9%) |
| Jan 1995 | - | $12.60 M(-116.8%) | -$85.90 M(-1.2%) |
| Oct 1994 | - | -$75.10 M(-2.1%) | -$86.90 M(+24.0%) |
| July 1994 | - | -$76.70 M(-243.9%) | -$70.10 M(+4.8%) |
| Apr 1994 | -$66.90 M(-56.2%) | $53.30 M(+359.5%) | -$66.90 M(-71.7%) |
| Jan 1994 | - | $11.60 M(-119.9%) | -$236.40 M(-3.4%) |
| Oct 1993 | - | -$58.30 M(-20.7%) | -$244.60 M(+26.3%) |
| July 1993 | - | -$73.50 M(-36.7%) | -$193.60 M(+26.9%) |
| Apr 1993 | -$152.60 M(+149.8%) | -$116.20 M(-3517.6%) | -$152.60 M(+116.1%) |
| Jan 1993 | - | $3.40 M(-146.6%) | -$70.60 M(+3.8%) |
| Oct 1992 | - | -$7.30 M(-77.5%) | -$68.00 M(-11.8%) |
| July 1992 | - | -$32.50 M(-5.0%) | -$77.10 M(+26.2%) |
| Apr 1992 | -$61.10 M(+455.5%) | -$34.20 M(-670.0%) | -$61.10 M(+83.5%) |
| Jan 1992 | - | $6.00 M(-136.6%) | -$33.30 M(-33.9%) |
| Oct 1991 | - | -$16.40 M(-0.6%) | -$50.40 M(+58.5%) |
| July 1991 | - | -$16.50 M(+157.8%) | -$31.80 M(+189.1%) |
| Apr 1991 | -$11.00 M(-350.0%) | -$6.40 M(-42.3%) | -$11.00 M(+139.1%) |
| Jan 1991 | - | -$11.10 M(-604.5%) | -$4.60 M(-170.8%) |
| Oct 1990 | - | $2.20 M(-48.8%) | $6.50 M(+51.2%) |
| July 1990 | - | $4.30 M | $4.30 M |
| Apr 1990 | $4.40 M | - | - |
FAQ
- What is Medtronic annual cash flow from financing activities?
- What is the all time high annual CFF for Medtronic?
- What is Medtronic annual CFF year-on-year change?
- What is Medtronic quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Medtronic?
- What is Medtronic quarterly CFF year-on-year change?
- What is Medtronic TTM cash flow from financing activities?
- What is the all time high TTM CFF for Medtronic?
- What is Medtronic TTM CFF year-on-year change?
What is Medtronic annual cash flow from financing activities?
The current annual CFF of MDT is -$4.45 B
What is the all time high annual CFF for Medtronic?
Medtronic all-time high annual cash flow from financing activities is $15.95 B
What is Medtronic annual CFF year-on-year change?
Over the past year, MDT annual cash flow from financing activities has changed by +$510.00 M (+10.28%)
What is Medtronic quarterly cash flow from financing activities?
The current quarterly CFF of MDT is -$534.00 M
What is the all time high quarterly CFF for Medtronic?
Medtronic all-time high quarterly cash flow from financing activities is $14.93 B
What is Medtronic quarterly CFF year-on-year change?
Over the past year, MDT quarterly cash flow from financing activities has changed by -$444.00 M (-493.33%)
What is Medtronic TTM cash flow from financing activities?
The current TTM CFF of MDT is -$5.12 B
What is the all time high TTM CFF for Medtronic?
Medtronic all-time high TTM cash flow from financing activities is $15.95 B
What is Medtronic TTM CFF year-on-year change?
Over the past year, MDT TTM cash flow from financing activities has changed by +$2.49 B (+32.71%)